Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies

US Patent 9090596 · Granted Jul 28, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted pyrazolo[3,4-d]pyrimidines as mTOR inhibitors2023
MTOR inhibitor compounds2022
Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan 2020
Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the 2020
Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related or2020
Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-rela2020
Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan re2019
Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the 2019
Heterocyclic compounds and use thereof in medicine and in cosmetics2019
Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan 2019
Method for the diagnosis of rosacea2018
Use of naratriptan in the treatment of rosacea2018